Home
Frank Yocca, Chief Scientific Officer: BioXcel Therapeutics BTAIQ Sell · Filed 24/12/17
Trade details
- Type
- Insider sale
- Amount
- $78.75
- Shares · price
- 225 sh · $0.35 a share
- Held after
- 28,931 sh
- Trade date
- 24/12/16
- Filed
- 24/12/17
- Days to filing
- 1 days
Sold 0.8% of holdings
- Share of holding sold
- 0.8%
BioXcel Therapeutics trades, last 26 weeks
What else happened in BioXcel Therapeutics around then
Filed or reported within 30 days of the trade day · 24/11/16~25/01/15Frank Yocca's recent trades
- Frank Yocca
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$7,461
6,845 sh
$7,461
Filed 05/22
Traded 05/20
- Frank Yocca
Planned sale10b5-1 planBioXcel Therapeutics
Planned sale10b5-1 planBioXcel Therapeutics
BTAIQ
$7,430
6,845 sh
$7,430
Filed 05/20
Traded 05/20
- Frank Yocca
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$74
205 sh
$74
Filed 24/12/17
Traded 24/12/16
- Frank Yocca
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$3,946
7,175 sh
$3,946
Filed 24/10/03
Traded 24/10/03
- Frank Yocca
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$245
355 sh
$245
Filed 24/09/17
Traded 24/09/16